Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is it an issue of timing delays or actual market / projects?

Seems to be a conflict in messages. First they have the projects, and it's only a matter of the timing that caused the revenue shortfall,

"The Company's revenue shortfall is based on its current assessment of the timing for prospective customer projects and other opportunities with various Federal, state and local agencies."

http://patriotscientific.com/index.php?option=com_content&task=view&id=230&Itemid=29

Now, by inference, they seem to be indicating they don't actually have the $3M to $6M in the pipeline already, but are trying to ACCESS these markets. If anyone can get clarification on that, please do.

"In addition to significantly increasing PDSG's pipeline of business opportunities and the size of systems integration projects it may pursue, the channel strategy also provides access to new markets, including Federal customers"

http://patriotscientific.com/index.php?option=com_content&task=view&id=258&Itemid=29

Share
New Message
Please login to post a reply